Department Researches & Publications

Faculty of Pharmacy

Assiut University

Department of Industrial Pharmacy

Researches

The department research plan participates in solving problems that face the pharmaceutical industry in the vicinity of Asyut City and others. Staff members are also supervising and teaching post-graduate students, Diploma, MSc. and Ph.D. students, and the proposed advanced and novel specializations in pharmaceutical sciences for the next 5 years plan listed below:

  1. Targeted drug delivery using Micro-/Nan particulate technologies (Polymeric particles, micro-emulsions, liposomes, etc.)
  2. Enhancing peptide and protein drug delivery via the oral and pulmonary routes.
  3. Controlled release formulation of drugs.
  4. Enhancing drug dissolution and bioavailability.
  5. Gastro-retentive technology.
  6. Transdermal drug delivery.
# Title Research Year
11 Clinical Translations of Nanomedicines; Key, challenges and Opportunities 2022
12 Design-of-experiment approach to quantify the effect of nano-sized silica on tableting properties of microcrystalline cellulose to facilitate direct compression tableting of binary blend containing a low-dose drug 2022
13 Design and optimization of PEGylated silver nanoparticles for efficient delivery of Doxorubicin to cancer cells 2022
14 Studying the Complex Formation of Sulfonatocalix[4]naphthalene and Meloxicam towards Enhancing Its Solubility and Dissolution Performance 2021
15 Selective Targeting of the Novel CK-10 Nanoparticles to the MDAMB- 231 Breast Cancer Cells 2021
16 Novel Green Biosynthesis of 5-Fluorouracil Chromium Nanoparticles Using Harpullia pendula Extract for Treatment of Colorectal Cancer 2021
17 Recent updates in COVID-19 with emphasis on inhalation therapeutics: nanostructured and targeting systems 2021
18 Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities 2021
19 Recent updates in COVID-19 with emphasis on inhalation therapeutics: nanostructured and targeting systems 2021
20 Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo 2021